Cementos Pacasmayo S.A.A. (CPACASC1)
Lima Stock Exchange · Peru · prices in PEN · close of 26 Oct 2026
Key indicators
| Last close | PEN 8.700 |
|---|---|
| 52-week range | 4.100 – 8.790 |
| Return, 1 month / 3 months | +3.6% / +8.7% |
| Return, 1 year / 3 years | +80.5% / +184.6% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 52.3% |
| Worst drawdown (1 year) | -12.0% |
| Average daily value traded | 0.29M PEN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cementos Pacasmayo is a Peruvian cement and construction materials company based in Lima. It makes and distributes cement, ready-mix concrete, aggregates and related products such as blocks and paving materials. Its customers are builders, contractors, retailers and infrastructure projects, with a strong presence in the northern part of Peru, where it operates plants and a distribution network serving local construction markets.
Cementos Pacasmayo S.A.A. trades under the code CPACASC1 on the Lima Stock Exchange in Peru, with its price quoted in Peruvian soles (PEN). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cementos Pacasmayo S.A.A. (CPACASC1) trades on the Lima Stock Exchange in Peru. It last closed at PEN 8.700 on 26 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 6 of 35 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 80.5% and over the last three months it rose 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Lima Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.5% | ||
| From 52-week high | 0.0% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | 19.5% | ||
| 12-month return, skipping the last month | 74.3% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 52.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.0% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.29M PEN | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | +3.6% |
| 3 months | +8.7% |
| 6 months | +19.5% |
| 1 year | +80.5% |
| 3 years | +184.6% |
| 5 years | +133.4% |
Signals
| 50-day / 200-day average | 8.362 / 7.601 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.090 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Nov 2024 | PEN 0.4100 |
| 23 Nov 2023 | PEN 0.4100 |
| 16 Nov 2022 | PEN 0.4200 |
| 21 Jun 2021 | PEN 0.7900 |
| 4 Dec 2020 | PEN 0.2300 |
| 6 Dec 2019 | PEN 0.3600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Lima Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.